The predictive value of ovarian reserve tests for miscarriage in a population of subfertile ovulatory women

Human Reproduction

Volumn 24, Issue 3, 2009, Pages 546-552

  Haadsma, M L ^a   Groen, H ^a   Fidler, V ^a   Seinen, L H M ^a   Broekmans, F J M ^b   Heineman, M J ^a,c   Hoek, A ^a  

^a UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

^b UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^c ACADEMIC MEDICAL CENTER   (Netherlands)

Author keywords

Miscarriage; Ovarian reserve; Ovarian reserve test; Predictive value; Pregnancy loss

Indexed keywords

CLOMIFENE CITRATE; FOLLITROPIN; INHIBIN B;

ADULT; AGE; ANTRAL FOLLICLE COUNT; ARTICLE; CELL COUNT; CLINICAL ASSESSMENT TOOL; CONTROLLED STUDY; FEMALE; HUMAN; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; OVARIAN RESERVE TEST; OVULATION; PREDICTION AND FORECASTING; PREGNANCY; SPONTANEOUS ABORTION; SUBFERTILITY; UNIVARIATE ANALYSIS;

EID: 61449254459     PISSN: 02681161     EISSN: 14602350     Source Type: Journal    
DOI: 10.1093/humrep/den384     Document Type: Article

References (48)

1. Abdalla H, Thum MY. An elevated basal FSH reflects a quantitative rather than qualitative decline of the ovarian reserve. Hum Reprod 2004;19:893-898.
2. Baird DT, Collins J, Egozcue J, Evers LH, Gianaroli L, Leridon H, Sunde A, Templeton A, Van Steirteghem A, Cohen J et al. Fertility and ageing. Hum Reprod Update 2005;11:261-276.
3. Boue A, Boue J, Gropp A. Cytogenetics of pregnancy wastage. Adv Hum Genet 1985;14:1-57.
4. Broekmans FJ, Kwee J, Hendriks DJ, Mol BW, Lambalk CB. A systematic review of tests predicting ovarian reserve and IVF outcome. Hum Reprod Update 2006;12:685-718.
5. De Koning CH, Popp-Snijders C, Martens F, Lambalk CB. Falsely elevated follicle-stimulating hormone levels in women with regular menstrual cycles due to interference in immunoradiometric assay. J Assist Reprod Genet 2000;17:457-459.
6. De Koning CH, Benjamins T, Harms P, Homburg R, Van Montfrans JM, Gromoll J, Simoni M, Lambalk CB. The distribution of FSH receptor isoforms is related to basal FSH levels in subfertile women with normal menstrual cycles. Hum Reprod 2006;21:443-446.
7. De Koning CH, McDonnell J, Themmen APN, De Jong FH, Homburg R, Lambalk CB. The endocrine and follicular growth dynamics throughout the menstrual cycle in women with consistently or variably elevated early follicular phase FSH compared with controls. Hum Reprod 2008;23: 1416-1423.
8. Eichenlaub-Ritter U. Genetics of oocyte ageing. Maturitas 1998;30:143-169.
9. Eimers JM, Te Velde ER, Gerritse R, Vogelzang ET, Looman CW, Habbema JD. The prediction of the chance to conceive in subfertile couples. Fertil Steril 1994;61:44-52.
10. Elter K, Kavak ZN, Gokaslan H, Pekin T. Antral follicle assessment after down-regulation may be a useful tool for predicting pregnancy loss in in vitro fertilization pregnancies. Gynecol Endocrinol 2005;21:33-37.
11. Freeman SB, Yang Q, Allran K, Taft LF, Sherman SL. Women with a reduced ovarian complement may have an increased risk for a child with Down syndrome. Am J Hum Genet 2000;66:1680-1683.
12. Gurbuz B, Yalti S, Ozden S, Ficicioglu C. High basal estradiol level and FSH/LH ratio in unexplained recurrent pregnancy loss. Arch Gynecol Obstet 2004;270:37-39.
13. Haadsma ML, Bukman A, Groen H, Roeloffzen EMA, Groenewoud ER, Heineman MJ, Hoek A. The number of small antral follicles (2-6 mm) determines the outcome of endocrine ovarian reserve tests in a subfertile population. Hum Reprod 2007;22:1925-1931.
14. Haadsma ML, Groen H, Fidler V, Bukman A, Roeloffzen EMA, Groenewoud ER, Broekmans FJM, Heineman MJ, Hoek A. The predictive value of ovarian reserve tests for spontaneous pregnancy in subfertile ovulatory women. Hum Reprod 2008;23:1800-1807.
15. Hanoch J, Lavy Y, Holzer H, Hurwitz A, Simon A, Revel A, Laufer N. Young low responders protected from untoward effects of reduced ovarian response. Fertil Steril 1998;69:1001-1004.
16. Harrell FE. Regression Modeling Strategies. New York: Springer, 2001.
17. Hassold T, Hunt P. To err (meiotically) is human: the genesis of human aneuploidy. Nat Rev Genet 2001;2:280-291.
18. Hassold T, Abruzzo M, Adkins K, Griffin D, Merrill M, Millie E, Saker D, Shen J, Zaragoza M. Human aneuploidy: incidence, origin, and etiology. Environ Mol Mutagen 1996;28:167-175.
19. Havryliuk Y, Dragisic KG, Rosenwaks Z, Spandorfer S. Baseline serum FSH levels in poor prognostic IVF patients: Do abnormal levels predict fetal aneuploidy? Fertil Steril 2006;86:S21.
20. Henderson SA, Edwards RG. Chiasma frequency and maternal age in mammals. Nature 1968;218:22-28.
21. Hendriks DJ, Broekmans FJ, Bancsi LF, de Jong FH, Looman CW, Te Velde ER. Repeated clomiphene citrate challenge testing in the prediction of outcome in IVF: a comparison with basal markers for ovarian reserve. Hum Reprod 2005;20:163-169.
22. Hofmann GE, Khoury J, Thie J. Recurrent pregnancy loss and diminished ovarian reserve. Fertil Steril 2000;74:1192-1195.
23. Kline J, Kinney A, Levin B, Warburton D. Trisomic pregnancy and earlier age at menopause. Am J Hum Genet 2000;67:395-404.
24. Kline J, Kinney A, Reuss ML, Kelly A, Levin B, Ferin M, Warburton D. Trisomic pregnancy and the oocyte pool. Hum Reprod 2004;19:1633- 1643.
25. Kwee J, Schats R, McDonnell J, Lambalk CB, Schoemaker J. Intercycle variability of ovarian reserve tests: results of a prospective randomized study. Hum Reprod 2004;19:590-595.
26. Lambalk CB, De Koning CH. Interpretation of elevated FSH in the regular menstrual cycle. Maturitas 1998;30:215-220.
27. Lekamge DN, Barry M, Kolo M, Lane M, Gilchrist RB, Tremellen KP. Anti-Mullerian hormone as a predictor of IVF outcome. Reprod Biomed Online 2007;14:602-610.
28. Levi AJ, Raynault MF, Bergh PA, Drews MR, Miller BT, Scott RT. Reproductive outcome in patients with diminished ovarian reserve. Fertil Steril 2001;76:666-669.
29. Ljunger E, Cnattingius S, Lundin C, Anneren G. Chromosomal anomalies in first-trimester miscarriages. Acta Obstet Gynecol Scand 2005;84:1103-1107.
30. Luna M, Grunfeld L, Mukherjee T, Sandler B, Copperman AB. Moderately elevated levels of basal follicle-stimulating hormone in young patients predict low ovarian response, but should not be used to disqualify patients from attempting in vitro fertilization. Fertil Steril 2007;87:782-787.
31. Maheshwari A, Fowler P, Bhattacharya S. Assessment of ovarian reserve-should we perform tests of ovarian reserve routinely? Hum Reprod 2006;21:2729-2735.
32. Massie JAM, Burney RO, Milki AA, Westphal LM, Lathi RB. Basal follicle-stimulating hormone as a predictor of fetal aneuploidy. Fertil Steril 2007;87:S7.
33. Metwally M, Ong KJ, Ledger WL, Li TC. Does high body mass index increase the risk of miscarriage after spontaneous and assisted conception? A meta-analysis of the evidence. Fertil Steril 2008;90:714-726.
34. Nasseri A, Mukherjee T, Grifo JA, Noyes N, Krey L, Copperman AB. Elevated day 3 serum follicle stimulating hormone and/or estradiol may predict fetal aneuploidy. Fertil Steril 1999;71:715-718.
35. O'Connor KA, Holman DJ, Wood JW. Declining fecundity and ovarian ageing in natural fertility populations. Maturitas 1998;30:127-136.
36. Rai R, Regan L. Recurrent miscarriage. Lancet 2006;368:601- 611.
37. Saldeen P, Kallen K, Sundstrom P. The probability of successful IVF outcome after poor ovarian response. Acta Obstet Gynecol Scand 2007;86:457-461.
38. Scott RT, Hofmann GE, Oehninger S, Muasher SJ. Intercycle variability of Day 3 follicle-stimulating hormone levels and its effect on stimulation quality in in vitro fertilization. Fertil Steril 1990;54:297-302.
39. Tarin JJ. Aetiology of age-associated aneuploidy: a mechanism based on the 'free radical theory of ageing'. Hum Reprod 1995;10:1563-1565.
40. Te Velde ER, Pearson PL. The variability of female reproductive ageing. Hum Reprod Update 2002;8:141-154.
41. Trout SW, Seifer DB. Do women with unexplained recurrent pregnancy loss have higher Day 3 serum FSH and estradiol values? Fertil Steril 2000;74:335-337.
42. Van der Steeg JW, Steures P, Eijkemans MJ, Habbema JD, Hompes PG, Broekmans FJ, Bouckaert PX, Bossuyt PM, Van der Veen F, Mol BW. Predictive value and clinical impact of basal follicle-stimulating hormone in subfertile, ovulatory women. J Clin Endocrinol Metab 2007;92: 2163-2168.
43. Van Montfrans JM, Dorland M, Oosterhuis GJ, Van Vugt JM, Rekers-Mombarg LT, Lambalk CB. Increased concentrations of follicle-stimulating hormone in mothers of children with Down's syndrome. Lancet 1999;353:1853- 1854.
44. Van Montfrans JM, Van Hooff MH, Huirne JA, Tanahatoe SJ, Sadrezadeh S, Martens F, Van Vugt JM, Lambalk CB. Basal FSH concentrations as a marker of ovarian ageing are not related to pregnancy outcome in a general population of women over 30 years. Hum Reprod 2004;19:430-434.
45. Van Rooij IA, Broekmans FJ, Scheffer GJ, Looman CW, Habbema JD, De Jong FH, Fauser BJ, Themmen AP, Te Velde ER. Serum antiMüllerian hormone levels best reflect the reproductive decline with age in normal women with proven fertility: a longitudinal study. Fertil Steril 2005;83: 979-987.
46. Van Rooij IA, Broekmans FJ, Hunault CC, Scheffer GJ, Eijkemans MJ, De Jong FH, Themmen AP, Te Velde ER. Use of ovarian reserve tests for the prediction of ongoing pregnancy in couples with unexplained or mild male infertility. Reprod Biomed Online 2006;12:182-190.
47. Visser JA, De Jong FH, Laven JS, Themmen AP. Anti-Müllerian hormone: a new marker for ovarian function. Reproduction 2006;31:1-9.
48. Wang JX, Norman RJ, Wilcox AJ. Incidence of spontaneous abortion among pregnancies produced by assisted reproductive technology. Hum Reprod 2004;19:272-277.